Treace Medical Financials

TMCI Stock  USD 8.69  0.44  5.33%   
Treace Medical Concepts is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. As of now, Treace Medical's Cash And Short Term Investments are increasing as compared to previous years. The Treace Medical's current Property Plant And Equipment Gross is estimated to increase to about 52.2 M, while Total Assets are projected to decrease to under 154.1 M. Key indicators impacting Treace Medical's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.590.617
Sufficiently Down
Very volatile
Current Ratio3.794.6214
Significantly Down
Slightly volatile
The essential information of the day-to-day investment outlook for Treace Medical includes many different criteria found on its balance sheet. An individual investor should monitor Treace Medical's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Treace Medical.

Net Income

(52.96 Million)

  

Treace Medical Stock Summary

Treace Medical competes with Rxsight, Axogen, Pulmonx Corp, Orthofix Medical, and Orthopediatrics Corp. Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida. Treace Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 248 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS89455T1097
CUSIP89455T109
LocationFlorida; U.S.A
Business Address100 Palmetto Park
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.treace.com
Phone904 373 5940
CurrencyUSD - US Dollar

Treace Medical Key Financial Ratios

Treace Medical Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets41.8M140.8M159.0M251.9M217.1M154.1M
Other Current Liab7.5M14.2M20.9M31.8M24.0M19.2M
Net Debt12.9M(76.5M)49.1M57.3M58.3M61.2M
Retained Earnings(21.4M)(41.9M)(84.7M)(134.2M)(190.0M)(180.5M)
Accounts Payable2.3M4.1M8.7M11.8M10.5M7.0M
Cash18.1M105.8M19.5M13.0M11.4M10.8M
Long Term Debt29.2M29.4M52.7M53.0M53.3M43.4M
Net Receivables14.5M18.6M29.2M38.1M40.8M27.8M
Inventory7.8M10.6M19.3M29.2M39.3M20.5M
Other Current Assets593K6.0M3.6M7.9M5.7M4.4M
Total Liab41.0M47.7M98.5M114.0M104.2M79.2M
Net Invested Capital23.8M122.4M113.2M190.9M166.2M115.7M
Total Current Assets41.0M138.0M133.4M198.4M161.4M128.5M
Net Working Capital29.4M119.8M103.2M153.3M126.5M101.4M

Treace Medical Key Income Statement Accounts

202020212022202320242025 (projected)
Net Interest Income(4.5M)(4.0M)(3.5M)193K(379K)(398.0K)
Interest Expense2.8M4.1M4.4M5.2M5.3M4.1M
Total Revenue57.4M94.4M141.8M187.1M209.4M133.7M
Gross Profit44.9M76.6M114.3M151.9M168.3M107.8M
Operating Income(891K)(16.5M)(34.8M)(51.4M)(55.7M)(52.9M)
Ebit855K(16.5M)(39.5M)(44.4M)(50.5M)(48.0M)
Research Development5.8M10.2M13.6M15.4M20.6M13.0M
Ebitda2.1M(15.8M)(34.8M)(39.0M)(42.1M)(40.0M)
Cost Of Revenue12.5M17.8M27.5M35.2M41.1M26.0M
Income Before Tax(3.7M)(20.6M)(42.8M)(49.5M)(55.7M)(53.0M)
Net Income(6.4M)(24.6M)(47.3M)(49.5M)(55.7M)(53.0M)
Income Tax Expense2.8M4.1M4.5M5.2M6.0M3.8M

Treace Medical Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(3.4M)(3.1M)(8.8M)(9.8M)(10.0M)(10.5M)
Investments(1.1M)(2.7M)(61.7M)(150.3M)35.4M37.1M
Change In Cash5.9M87.8M(86.4M)(6.5M)(1.6M)(1.6M)
Free Cash Flow(5.6M)(19.9M)(45.5M)(46.0M)(48.8M)(46.3M)
Depreciation1.2M685K2.1M5.4M8.4M8.8M
Other Non Cash Items221K176K7.7M2.0M10.2M10.7M
Capital Expenditures1.1M2.7M14.8M11.5M11.6M7.9M
Net Income(3.7M)(20.6M)(42.8M)(49.5M)(55.7M)(53.0M)
End Period Cash Flow18.1M105.8M19.5M13.0M11.4M10.8M

Treace Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Treace Medical's current stock value. Our valuation model uses many indicators to compare Treace Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Treace Medical competition to find correlations between indicators driving Treace Medical's intrinsic value. More Info.
Treace Medical Concepts is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, Treace Medical's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Treace Medical's earnings, one of the primary drivers of an investment's value.

Treace Medical Concepts Systematic Risk

Treace Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Treace Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Treace Medical Concepts correlated with the market. If Beta is less than 0 Treace Medical generally moves in the opposite direction as compared to the market. If Treace Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Treace Medical Concepts is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Treace Medical is generally in the same direction as the market. If Beta > 1 Treace Medical moves generally in the same direction as, but more than the movement of the benchmark.

Treace Medical Thematic Clasifications

Treace Medical Concepts is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
DrugsView
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Today, most investors in Treace Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Treace Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Treace Medical growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.78)

As of now, Treace Medical's Price Earnings To Growth Ratio is increasing as compared to previous years.

Treace Medical March 25, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Treace Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Treace Medical Concepts. We use our internally-developed statistical techniques to arrive at the intrinsic value of Treace Medical Concepts based on widely used predictive technical indicators. In general, we focus on analyzing Treace Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Treace Medical's daily price indicators and compare them against related drivers.

Complementary Tools for Treace Stock analysis

When running Treace Medical's price analysis, check to measure Treace Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Treace Medical is operating at the current time. Most of Treace Medical's value examination focuses on studying past and present price action to predict the probability of Treace Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Treace Medical's price. Additionally, you may evaluate how the addition of Treace Medical to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas